跳至主要内容
临床试验/NCT07150065
NCT07150065已完成2 期

Efficacy of Levofloxacin Versus Ciprofloxacin in the Treatment of Childhood Typhoid Fever

Avicenna Medical College Lahore1 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2025年2月7日最近更新:
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
360
试验地点
1
主要终点
Total time required to resolve fever

研究概览

简要总结

Sample size of 360 children with typhoid fever were enrolled and randomly divided in two groups. All the children were enrolled in the trial from Pediatrics emergency. Informed consent was obtained from parents. Demographics (name, age of child, sex of the child, duration of fever, weight, season, socioeconomic status and residence) were noted. Then children were admitted and randomly divided in two groups by using lottery method. In group A, children were given oral 200 mg levofloxacin tablet. In group B, children were given oral 900-1,000 mg ciprofloxacin tablet. All children were followed-up pediatric wards for 7 days. If fever was resolved within 5 days (body temperature falls <99oF and remain stable for at least 5 days), then efficacy was labeled. Total time required to resolve fever i.e. body temperature <99oF in all children was also noted. All this information was recorded

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
1 Year 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children of age 1-12 years
  • Typhoid fever
  • Confirmed on blood culture

排除标准

  • Recurrent typhoid within 3 months
  • Intestinal perforation
  • Evidence of progressive or complicated disease
  • Inability to swallow oral medication
  • Hypersensitivity to trial drugs
  • Already taken fluoroquinolone, third generation cephalosporin or macrolide in last week

研究组 & 干预措施

Group A with oral 200 mg levofloxacin tablet

Active Comparator

Group A included 180 participants. They were given oral 200 mg levofloxacin tablet. All children were followed-up pediatric wards for 7 days. If fever was resolved within 5 days (body temperature falls <99oF and remain stable for at least 5 days), then efficacy was labeled. Total time required to resolve fever i.e. body temperature <99oF in all children was also noted.

干预措施: Levofloxacin (Drug)

Group B with oral 900-1,000 mg ciprofloxacin tablet

Active Comparator

. In group B, children were given oral 900-1,000 mg ciprofloxacin tablet. All children were followed-up pediatric wards for 7 days. If fever was resolved within 5 days (body temperature falls <99oF and remain stable for at least 5 days), then efficacy was labeled. Total time required to resolve fever i.e. body temperature <99oF in all children was also noted

干预措施: ciprofloxacin (Drug)

结局指标

主要结局

Total time required to resolve fever

时间窗: 5 days

Clinical efficacy involved resolution of fever within 5 days (body temperature falls \<99oF and remain stable for at least 5 days). Total time required to resolve fever i.e. body temperature \<99oF in all children was also noted.

次要结局

未报告次要终点

研究者

发起方
Avicenna Medical College Lahore
申办方类型
Other
责任方
Principal Investigator
主要研究者

Muhammad Iqbal

Principal Investigator

Avicenna Medical College Lahore

研究点 (1)

Loading locations...

相似试验